Stocks and Investing Stocks and Investing
Tue, March 21, 2017

BGS, PXH, CBPO, RWO, EPI, ERX Are Seasonally Ripe To Go Up In the Next Five Weeks


Published on 2017-03-21 01:45:18 - WOPRAI
  Print publication without navigation


March 21, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of B&G Foods Inc (NYSE:BGS), PowerShares FTSE RAFI Emerging Markets Portfolio (NYSE:PXH), China Biologic Products, Inc. (NASDAQ:CBPO), SPDR DJ Wilshire Global Real Estate ETF (NYSE:RWO), WisdomTree India Earnings Fund ETF (NYSE:EPI), Direxion Energy Bull 3x Shares (NYSE:ERX) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Up:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  BGS     B&G Foods Inc                    2.62%            88.89% (8 of 9)      Friday, March 24th 2017
  PXH     PowerShares FTSE RAFI Emerging Markets Portfolio  7.90%            88.89% (8 of 9)      Wednesday, April 26th 2017
  CBPO    China Biologic Products, Inc.    9.26%            100.00% (8 of 8)     Monday, April 10th 2017
  RWO     SPDR DJ Wilshire Global Real Estate ETF  2.30%            87.50% (7 of 8)      Friday, March 31st 2017
  EPI     WisdomTree India Earnings Fund ETF  3.98%            88.89% (8 of 9)      Wednesday, March 29th 2017
  ERX     Direxion  Energy Bull 3x Shares  17.14%           87.50% (7 of 8)      Thursday, April 27th 2017
B&G Foods Inc (NYSE:BGS) - B&G Foods, Inc. manufactures, sells, and distributes a portfolio of shelf-stable, and frozen food and household products in the United States, Canada, and Puerto Rico. Its products include frozen and canned vegetables, hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, wine vinegar, maple syrup, molasses, salad dressings, pizza crusts, Mexican-style sauces, dry soups, taco shells and kits, salsas, pickles, peppers, tomato-based products, puffed corn and rice snacks, nut clusters, and other specialty products. The company markets its products under various brands, including Ac cent, B&G, B&M, Baker s Joy, Bear Creek Country Kitchens, Brer Rabbit, Canoleo, Cary s, Cream of Rice, Cream of Wheat, Devonsheer, Don Pepino, Durkee, Emeril s, Grandma s Molasses, Green Giant, JJ Flats, Joan of Arc, Las Palmas, Le Sueur, MacDonald s, Mama Mary s, Maple Grove Farms of Vermont, Molly McButter, Mrs. Dash, New York Flatbreads, New York Style, Old London, Original Tings, Ortega, Pirate s Booty, Polaner, Red Devil, Regina, Sa-s n, Sclafani, Smart Puffs, Spice Islands, Spring Tree, Sugar Twin, Tone s, Trappey s, TrueNorth, Underwood, Vermont Maid, Victoria, Weber, and Wright s. It also sells and distributes household products under the Static Guard brand. The company offers its products directly, as well as through a network of independent brokers and distributors to supermarket chains, food service outlets, mass merchants, warehouse clubs, non-food outlets, and specialty distributors. The company was formerly known as B&G Foods Holdings Corp. and changed its name to B&G Foods, Inc. in October 2004. B&G Foods, Inc. was founded in 1996 and is headquartered in Parsippany, New Jersey..

PowerShares FTSE RAFI Emerging Markets Portfolio (NYSE:PXH) - PowerShares FTSE RAFI Emerging Markets Portfolio.

China Biologic Products, Inc. (NASDAQ:CBPO) - China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People s Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also provides human immunoglobulin and immunoglobulin for intravenous injection products for original and secondary immunoglobulin deficiency, and auto-immune deficiency diseases; human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; and human tetanus immunoglobulin for the prevention and therapy of tetanus. In addition, it offers placenta polypeptide for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia, as well as assists in postoperative healing; factor VIII for treating coagulopathies; and human prothrombin complex concentrate for treating congenital and acquired clotting factor II, VII, IX, X deficiency, as well as excessive anticoagulant, vitamin K deficiency, etc. Further, the company is developing human hepatitis B immunoglobulin (pH4) for intravenous injection; human fibrinogen; immune globulin intravenous; human antithrombin III; human cytomegalovirus immunoglobulin; human coagulation factor IX; and human fibrin sealant products. The company sells its products directly, as well as through distributors. China Biologic Products, Inc. is headquartered in Beijing, the People s Republic of China..

SPDR DJ Wilshire Global Real Estate ETF (NYSE:RWO) - SPDR DJ Wilshire Global Real Estate ETF.

WisdomTree India Earnings Fund ETF (NYSE:EPI) - Wisdomtree India Earnings Fund Etf.

Direxion Energy Bull 3x Shares (NYSE:ERX) - Direxion Daily Energy Bull 3x.

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net


Contributing Sources